Skip to content

S. 543 · 118th Congress (2023–2025)

CCM–CARE Act of 2023

Cerebral Cavernous Malformations Clinical Awareness, Research, and Education Act of 2023 or the CCM-CARE Act of 2023

This bill requires the National Institutes of Health (NIH) and other agencies to expand and coordinate their efforts to research cerebral cavernous malformation. (Cerebral cavernous malformation is a condition in which blood vessels in the brain and spinal cord become enlarged, which can lead to seizures, paralysis, hearing or vision loss, and bleeding in the brain.)

The NIH must (1) award grants for medical, clinical, and pharmacological research; (2) award grants to support a network of clinical research centers intended to develop a cure for the condition; and (3) convene a Cerebral Cavernous Malformations Research Consortium to develop programs for clinicians, scientists, and patients.

The Centers for Disease Control and Prevention must award grants to research entities for collecting and reporting data about cerebral cavernous malformation.

The Food and Drug Administration must accelerate the clinical trial process for cerebral cavernous malformation by supporting (1) appropriate laboratory indicators of the condition, (2) the qualification of clinical outcome measures related to quality of life, (3) investigational drug applications, and (4) expedited peer-review pathways.

Show official title

A bill to increase research, education, and treatment for cerebral cavernous malformations.

Expired in Senate committee

Derived from the legislative history, not an official disposition.

Latest actionReferred to committee

This bill’s path

This is S. 543’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed Senate

  3. Passed House

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Sen. Ben Ray Lujan (D-NM)
Cosponsors
1 cosponsor

1 original · 0 later

  1. Sen. Martin Heinrich (D-NM)· Original · Feb 28, 2023
Policy area
Health
Subjects
  • Cardiovascular and respiratory health
  • Drug safety, medical device, and laboratory regulation
  • Drug therapy
  • Health care quality
  • Health facilities and institutions
  • Health information and medical records
  • Health promotion and preventive care
  • Medical research
  • 2 more
    • Neurological disorders
    • Research administration and funding

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in Senate

    Document: Introduced in Senate

    Sources
  2. Latest

    Referred to committee

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Sources
  3. Expired

    Introduced → Referred to Senate Health, Education, Labor, and Pensions → No further action before the 118th Congress ended.

Committees

  1. SenateHealth, Education, Labor, and PensionsReferred Feb 28, 2023

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in Senate
Titles (3)
  1. CCM–CARE Act of 2023

    Display title, Short title · Introduced in Senate

  2. Cerebral Cavernous Malformations Clinical Awareness, Research, and Education Act of 2023

    Short title · Introduced in Senate

  3. A bill to increase research, education, and treatment for cerebral cavernous malformations.

    Official title · Introduced in Senate